Home/Neuronasal/Tom Bradshaw

TB

Tom Bradshaw

CEO

Therapeutic Areas

Neurology Traumatology

Neuronasal Pipeline

Drug	Indication	Phase
Intranasal NAC	Mild Traumatic Brain Injury (mTBI/Concussion)	Pre-clinical

Leadership Team at Neuronasal

Joe Hulihan, MD

Chief Medical Officer (CMO)

Douglas A. Greene, MD

Head of R&D and Senior Clinical Advisor

View full Neuronasal profile